Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Teva Pharmaceutical (TEVA)
NYSE:TEVA
Teva Pharmaceutical (TEVA) Ownership - Who Owns Teva Pharmaceutical?
6,392 Followers
Teva Pharmaceutical (TEVA) Ownership Overview
0.83% Insiders
14.72% Mutual Funds
2.78% Other Institutional Investors
81.67% Public Companies and Individual Investors
The ownership structure of Teva Pharmaceutical (TEVA) stock is a mix of institutional, retail and individual investors. Approximately 17.50% of the company’s stock is owned by Institutional Investors, 0.83% is owned by Insiders and 81.67% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Mar 07, 2024 | Mark Sabag Evp, International Markets | Sold | $1352000 |
| Feb 21, 2024 | Eric Drape Executive Vp Global Operations | Sold | $2261056 |
| Feb 05, 2024 | Amir Weiss Cao | Sold | $392945 |
| Aug 09, 2023 | Eliyahu Sharon Kalif Evp & Cfo | Sold | $341766 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Dec 31, 2023 | Bought | $658210 | |
| Dec 31, 2023 | Sold | $762892 | |
| Dec 31, 2023 | Bought | $1443517 | |
| Dec 31, 2023 | Sold | $1875681 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 58,734,848 | Institution | 5.24% | 777,062,039 | |
| 39,840,286 | Institution | 3.55% | 527,086,984 | |
| 26,231,184 | Institution | 2.34% | 347,038,564 | |
| 22,126,322 | Institution | 1.97% | 292,731,240 | |
| 17,949,245 | Institution | 1.60% | 237,468,511 | |
| 14,000,000 | Institution | 1.25% | 185,220,000 | |
| 6,727,432 | Institution | 0.60% | 89,003,925 | |
| 5,996,836 | Institution | 0.53% | 79,338,140 | |
| 3,875,000 | Institution | 0.35% | 51,266,250 | |
| 3,500,000 | Institution | 0.31% | 46,305,000 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 58,734,848 | Institution | 5.24% | 777,062,039 | |
| 39,840,286 | Institution | 3.55% | 527,086,984 | |
| 17,949,245 | Institution | 1.60% | 237,468,511 | |
| 14,000,000 | Institution | 1.25% | 185,220,000 | |
| 6,727,432 | Institution | 0.60% | 89,003,925 | |
| 3,500,000 | Institution | 0.31% | 46,305,000 | |
| 3,260,656 | Institution | 0.29% | 43,138,479 | |
| 3,229,166 | Institution | 0.29% | 42,721,866 | |
| 2,979,500 | Institution | 0.27% | 39,418,785 | |
| 2,717,045 | Institution | 0.24% | 35,946,505 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 6,637,228 | Institution | 0.59% | 87,810,526 | |
| 3,512,782 | Institution | 0.31% | 46,474,106 | |
| 2,333,414 | Institution | 0.21% | 30,871,067 | |
| 1,340,239 | Institution | 0.12% | 18,589,115 | |
| 1,256,415 | Institution | 0.11% | 16,710,320 | |
| 1,066,016 | Institution | 0.10% | 14,103,392 | |
| 944,136 | Institution | 0.08% | 12,490,919 | |
| 902,355 | Institution | 0.08% | 11,938,157 | |
| 814,545 | Institution | 0.07% | 10,776,430 | |
| 704,123 | Institution | 0.06% | 9,766,186 |
FAQ
Who Owns Teva Pharmaceutical (TEVA)?
According to the latest TipRanks data, approximately 2.78% of the company's stock is held by institutional investors, 0.83% is held by insiders, and 81.67% is held by retail investors.
What percentage of Teva Pharmaceutical (TEVA) stock is held by institutional investors?
According to the latest TipRanks data, approximately 2.78% of Teva Pharmaceutical (TEVA) stock is held by institutional investors.
What percentage of Teva Pharmaceutical (TEVA) stock is held by retail investors?
According to the latest TipRanks data, approximately 81.67% of Teva Pharmaceutical (TEVA) stock is held by retail investors.
Who owns the most shares of Teva Pharmaceutical (TEVA)?
Growth Fund of America owns the most shares of Teva Pharmaceutical (TEVA).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.